Deadline: 24-Oct-24
Pfizer and the National Bleeding Disorders Foundation are collaborating to offer a new grant opportunity seeking proposals for independent medical education initiatives that will provide education for physicians and multidisciplinary teams (MDTs) to enable shared decisions making (SDM) discussions on the emerging therapeutic options for treatment of hemophilia and equitable education for people with hemophilia to empower them to make evidence-based treatment choices.
Grants will be awarded in support of local (grass roots) independent medical education initiatives that will result in the measurable improvement of the medical and scientific understanding of emerging treatment options for people living with hemophilia and the MDTs that provide them care.
Specific Area of Interest
- It is the intent to support continuing education activities/programs that focus on addressing the educational needs (at a local level) for people living with hemophilia (PLwH) and the multidisciplinary teams that care for them.
- Educating on the evolving treatment landscape (i.e. genetic medicine, rebalancing strategies) for hemophilia to improve the understanding of these novel approaches.
- Discussing shared decision making (SDM) and practical approaches on how SDM can be incorporated into hemophilia patient care.
- Incorporate the lived-experience and perspectives of PLwH and/or caregivers in the project design where possible, ensuring the views are representative of a cross-section of the local patient population (racial, ethnic and culturally diverse).
- Examples of educational formats that will be considered under this RFP include but are not limited to:
- Multi-activity or tiered education that builds over time such as a series of activities or curriculum-based learning,
- Educational sessions during live conferences and live meetings,
- Online articles, newsletter articles, training courses, webinars, podcasts,
- Social media posted & linked content,
- All learning resources such as videos, infographics, animations
Funding Information
- Individual projects requesting up to $15,000 will be considered. The estimated total available budget related to this RFP is $100,000.
Target Audience
- People living with hemophilia, caregivers and members of multidisciplinary teams that care for Hemophilia patients including but not limited to Hematologists, Pharmacists, Specialty Nurses, Genetic Counsellors, and other Physicians.
Eligibility Criteria
- Geographic Scope:
- United States,
- Puerto Rico and
- Guam
- Applicant
- Eligible applicants include medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); PAGs or other non-profit organizations; professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).
- The project/program lead must be an employee or contractor of the requesting organization.
- For projects offering continuing education credit, the requesting organization must be accredited.
For more information, visit Pfizer.
